ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,352.00
10.50 (0.78%)
Last Updated: 10:07:28
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.50 0.78% 1,352.00 1,351.00 1,352.00 1,353.00 1,341.00 1,341.00 1,012,497 10:07:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.33 55.61B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,341.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.61 billion. Gsk has a price to earnings ratio (PE ratio) of 11.33.

Gsk Share Discussion Threads

Showing 26426 to 26448 of 34075 messages
Chat Pages: Latest  1063  1062  1061  1060  1059  1058  1057  1056  1055  1054  1053  1052  Older
DateSubjectAuthorDiscuss
04/5/2021
15:18
I have just found out the AGM is covered online by LUMI tomorrow. My problem is that it says I will need a SRN and a PIN to access. I have tried my broker Interactive Investor but, so far. they only say they will try to get back to me. Anyone with II know if this info is available in my account online? I can't find it. Thanks
mcflies
04/5/2021
14:56
(Alliance News) - GlaxoSmithKline PLC investee ViiV Healthcare on Tuesday said US health regulators have kicked off rolling review of its Cabotegravir HIV prevention drug.

The rolling submission for a new drug application allows ViiV to submit portions of data for regulatory approval from the US Food & Drug Administration. It means ViiV does not have to wait until all data is ready for submission.

Cabotegravir is a HIV pre-exposure prophylaxis, or PrEP, drug. ViiV said submission of the drug will be based on results from two phase IIb/III trials.

"With today's announcement we're one step closer to being able to provide the first, long-acting,

therapy to prevent HIV," ViiV Head of Research & Development Kimberly Smith said.

ViiV is majority-owned by GSK, with Pfizer Inc and Shionogi Ltd also owning stakes.

poikka
04/5/2021
14:09
Thanks. That is the article in full. The strange thing is that, unlike other Covid hit sectors, pharma has been slow to show any share price recovery?
alex1621
04/5/2021
13:10
The key date is 23 June 2021, the capital markets day, when the projections for both new entities are placed on the table. If it's unimpressive we might see Elliot et al show their teeth.
alex1621
04/5/2021
12:56
She desperately needs to pull something out of the hat tomorrow or she will be in a very weak position. She may have done little wrong in steering the company in a new direction, but her total failure to keep analysts and stock market on side is quite unforgivable.
mcflies
04/5/2021
12:36
Monty must be on half term this week!
spoole5
04/5/2021
12:12
GSK shareprice below what it was 25 years, nothing much will change, except dividends will be cut, if not for Elliott speculation I reckon 1225p on those figures the other day.
montyhedge
04/5/2021
07:12
Nothing special there .... 37.67 USD +0.33 (0.88%)
tradermichael
04/5/2021
07:05
NYSE. GSK .There chart above
notbitcoin
04/5/2021
06:56
What listing are you looking at, please?
tradermichael
03/5/2021
20:21
Up 30p in USA.Rumours could be true
notbitcoin
03/5/2021
17:33
Pfizer up state side 2.7% , hopefully good omens for GSK tomorrow
whatsup32
03/5/2021
15:40
Maybe with Elliott arriving she might not progress beyond the split but cannot see her moving on before then. Wouldn’t achieve anything anyway, the die is cast pharma wise for the next couple of years
daneswooddynamo
03/5/2021
15:19
If you like, but 30th June seems an awfully long way off when you're clinging to the cliff edge by your immaculately manicured finger nails....spud
spud
03/5/2021
14:38
Is that a rolling quarterly forecast Spud?
daneswooddynamo
03/5/2021
14:02
We had same issue at Aviva , with Tulloch. Got rid of him and let’s get rid of her. Wonder how much she’ll get paid for failure , probably in millions .
whatsup32
03/5/2021
14:01
A similar situation to the dopey bird at Imperial Brands.
meijiman
03/5/2021
13:54
EW out before end Q2. spud
spud
03/5/2021
13:07
Small article in the Times today.

“ large shareholders have made contact with the New York hedge fund since its emergence on the shareholder register last month. It has a stake of less then 5% in the £68B co”

States chiefs position in doubt and there is no desire to protect her .

Update is due June 23

whatsup32
03/5/2021
09:26
No worries. Have a nice day
whatsup32
03/5/2021
08:26
Oh my apologies WhatsUp!
markbelluk
03/5/2021
07:33
Am no chartist but looks to me as though broken out of long term down channel so should be better long term hold
I am holding small amount

ttg100
03/5/2021
06:45
If not for the Elliott so call share purchase, not a word from them, they can't do sweet FA with a small stake.But they are underpinning the shareprice at this high level. Because on those quarterly figures GSK should be 1225p.
montyhedge
Chat Pages: Latest  1063  1062  1061  1060  1059  1058  1057  1056  1055  1054  1053  1052  Older